Federal recipient
Anacor Pharmaceuticals, Inc.
$0 committed in FY2025 — no awards to them that year.See all years →Jump to FY2020 →
- Parent company
- Pfizer Inc.
- District
- NY-12
- Location
- 235 E 42ND ST, New York, NY, 10017
- UEI
- HGNKDH1DLM86
- DUNS
- 128824484
- Also known as
- Anacor Pharmaceuticals Inc
What they sell
Top products and services Anacor Pharmaceuticals, Inc. sells the government under contract, by dollars committed.
R&D- Medical: Other (Applied Research/Exploratory Development)
$7.8M
Competition
How many of Anacor Pharmaceuticals, Inc.'s priced contract actions drew exactly one offer — a competition on paper with a single bidder. A high share doesn't prove anything improper; it's a flag worth a second look.
Multiple offers
2
100%
Committed by fiscal year
Dollars committed to Anacor Pharmaceuticals, Inc., per fiscal year (FY2018–FY2020).
How to read these numbers
- Committed to this recipient
The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.
- Lifetime vs. a single year
The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.
- “Active in FY X”
A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.
- Names come raw
Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.
- The colored bars
Every bar on this page splits by how the money moves:
Direct payments
